@article{136bab0debcc454c84a881c3c43bcc73,
title = "The 2022 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part I. Duplex Scanning and Treatment of Superficial Truncal Reflux: Endorsed by the Society for Vascular Medicine and the International Union of Phlebology",
abstract = "The Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society collaborated to update the 2011 Society for Vascular Surgery/American Venous Forum clinical practice guidelines and provide new evidence-based recommendations on critical issues affecting the care of patients with varicose veins. Each recommendation is based on a recent, independent systematic review and meta-analysis of the diagnostic tests and treatments options for patients with lower extremity varicose veins. Part I of the guidelines includes evidence-based recommendations for the evaluation of patients with CEAP (Clinical Class, Etiology, Anatomy, Pathology) class 2 varicose vein using duplex ultrasound scanning and other diagnostic tests, open surgical treatment (ligation and stripping) vs endovenous ablation techniques, thermal vs nonthermal ablation of the superficial truncal veins, and management of incompetent perforating veins in CEAP class 2 disease. We have also made recommendations on the concomitant vs staged treatment of varicose tributaries using phlebectomy or liquid or foam sclerotherapy (with physician-compounded foam or commercially prepared polidocanol endovenous microfoam) for patients undergoing ablation of incompetent superficial truncal veins.",
keywords = "Ablation, Cyanoacrylate, Endovascular, Endovenous, Guidelines, Laser, Mechanicochemical ablation, Polidocanol endovenous microfoam, Radiofrequency, Sclerotherapy, Varicose veins, Venous insufficiency",
author = "Peter Gloviczki and Lawrence, {Peter F.} and Wasan, {Suman M.} and Meissner, {Mark H.} and Jose Almeida and Brown, {Kellie R.} and Bush, {Ruth L.} and {Di Iorio}, Michael and John Fish and Eri Fukaya and Gloviczki, {Monika L.} and Anil Hingorani and Arjun Jayaraj and Raghu Kolluri and Murad, {M. Hassan} and Obi, {Andrea T.} and Ozsvath, {Kathleen J.} and Singh, {Michael J.} and Satish Vayuvegula and Welch, {Harold J.}",
note = "Funding Information: Author conflict of interest: J.F. is a paid speaker for Janssen Pharmaceuticals. M.L.G. has been paid a consulting fee by VitasupportMD and is on their advisory board. R.K. is a paid consultant for Abbott Laboratories, Auxetics, Avail Medsystems, Boston Scientific, Inari, Medtronic, Penumbra, Prairie Education and Research Co-operative, Philips, SurModics, and Syntactx. M.H. Murad was funded by the Society for Vascular Surgery to conduct systematic reviews and provide methodology expertise. A.T.O. is a primary investigator for preclinical research grants funded by Medtronic and SurModics . K.J.O. is an Intersocietal Accreditation Commission board member, a speaker/U.S. course host for Medtronic, and a speaker for Boston Scientific. P.G., P.F.L., S.M.W., M.H. Meissner, J.A., K.B., R.L.B., M.D., E.F., A.H., A.J., S.V., and H.J.W. have no conflicts of interest. Publisher Copyright: {\textcopyright} 2022",
year = "2022",
doi = "10.1016/j.jvsv.2022.09.004",
language = "English (US)",
journal = "Journal of Vascular Surgery: Venous and Lymphatic Disorders",
issn = "2213-333X",
publisher = "Elsevier Inc.",
}